Cherrymed Pharmaceuticals Private Limited
About Cherrymed Pharmaceuticals Private Limited
Data last updated:
Cherrymed Pharmaceuticals Private Limited is a private limited company based in Tanda, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 22 June 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24230UP2016PTC084274. Its GSTIN is 09AAGCC5252K2ZE (Uttar Pradesh). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Reena Maurya and Vijay Kumar Kushwaha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Railway Station Khaspur Ambedkar Nagar, Tanda, Uttar Pradesh, India – 224190.
As per the financials filed for FY 2023, the company reported a revenue of ₹12.45 Lakh, a decline of 36% compared to the previous year. For the same year it recorded a net loss of ₹4,763 (net margin -0.4%) and EBITDA of ₹83,615 (EBITDA margin 6.7%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 1% over five years.
As per MCA filings, the company has open charges of ₹9.5 Lakh on record.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressRailway Station Khaspur Ambedkar Nagar, Tanda, Uttar Pradesh, India – 224190
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Cherrymed Pharmaceuticals Private Limited
The main business activity of Cherrymed Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Cherrymed Pharmaceuticals Private Limited FY 2025 filings available
Cherrymed Pharmaceuticals Private Limited reported revenue of ₹12.45 Lakh (down 36% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Cherrymed Pharmaceuticals Private Limited
Revenue fell 36% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA fell 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Cherrymed Pharmaceuticals Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹83,615 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹4,763 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Cherrymed Pharmaceuticals Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -0.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Cherrymed Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Cherrymed Pharmaceuticals Private Limited
Cherrymed Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dolce Pharmaceuticals Private Limited | ₹12.5 Lakh (FY 2019) | •••• | •••• | 145285.0% | •••• | Boisar, Maharashtra, India |
| Sure-Life Pharmaceuticals Private Limited | ₹12.48 Lakh (FY 2025) | •••• | •••• | -45.0% | •••• | Lucknow, Uttar Pradesh, India |
| Fledgling Pharmaceuticals Private Limited | ₹12.47 Lakh (FY 2025) | •••• | •••• | 140.0% | •••• | Gmc, Assam, India |
| Shypram Pharmaceuticals Private Limited | ₹12.46 Lakh (FY 2021) | •••• | •••• | -49.0% | •••• | Ahmedabad, Gujarat, India |
| Ragnar Pharmaceuticals Private Limited | ₹12.45 Lakh (FY 2024) | •••• | •••• | 22.0% | •••• | Kanpur, Uttar Pradesh, India |
| Cherrymed Pharmaceuticals Private Limited this company | ₹12.45 Lakh (FY 2023) | •••• | •••• | -36.0% | •••• | Tanda, Uttar Pradesh, India |
| Amigos Pharmaceuticals Private Limited | ₹12.44 Lakh (FY 2019) | •••• | •••• | 11.0% | •••• | Pune, Maharashtra, India |
| Craton Pharmaceuticals Private Limited | ₹12.37 Lakh (FY 2021) | •••• | •••• | -29.0% | •••• | Vadodara, Gujarat, India |
| Care First Pharmaceuticals Private Limited | ₹12.36 Lakh (FY 2024) | •••• | •••• | •••• | Delhi, India | |
| Meditrox Pharmaceuticals Private Limited | ₹12.35 Lakh (FY 2020) | •••• | •••• | 90.0% | •••• | Thanesar, Haryana, India |
| Mid Kampf Pharmaceuticals Private Limited | ₹12.35 Lakh (FY 2024) | •••• | •••• | 4.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Cherrymed Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Cherrymed Pharmaceuticals Private Limited
Cherrymed Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Reena Maurya | Director | 14 Nov 2021 | 4 Years 11 Months | Current |
| Vijay Kumar Kushwaha | Director | 22 Jun 2016 | 10 Years 3 Months | Current |
Ownership and Shareholding of Cherrymed Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Cherrymed Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Mar 2017 | Bank of India | ₹9.5 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Cherrymed Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Cherrymed Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Cherrymed Pharmaceuticals Private Limited
Cherrymed Pharmaceuticals Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Reena Maurya was appointed as Director on 14 Nov 2021.
Credit Ratings, Litigation & Regulatory Alerts for Cherrymed Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Cherrymed Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Cherrymed Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Cherrymed Pharmaceuticals Private Limited
Cherrymed Pharmaceuticals has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCC5252K2ZE | Uttar Pradesh | Active | 06 Aug 2022 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Cherrymed Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cherrymed Pharmaceuticals Private Limited
Cherrymed Pharmaceuticals is an active private limited company based in Tanda, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 22 June 2016 (10+ years old) and is registered under CIN U24230UP2016PTC084274.
Cherrymed Pharmaceuticals reported revenue of ₹12.45 Lakh for FY 2023 (down 36% YoY).
Cherrymed Pharmaceuticals has 2 current directors:
- Reena Maurya - Director
- Vijay Kumar Kushwaha - Director
Cherrymed Pharmaceuticals reported a net loss of ₹4,763 (net margin -0.4%) and EBITDA of ₹83,615 (EBITDA margin 6.7%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Cherrymed Pharmaceuticals is -12% over three years and 1% over five years. In the latest year (FY 2023) revenue fell 36%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Cherrymed Pharmaceuticals is 09AAGCC5252K2ZE, registered in Uttar Pradesh. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Cherrymed Pharmaceuticals is U24230UP2016PTC084274. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cherrymed Pharmaceuticals was incorporated on 22 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Cherrymed Pharmaceuticals by revenue are Dolce Pharmaceuticals Private Limited, Sure-Life Pharmaceuticals Private Limited, Fledgling Pharmaceuticals Private Limited, Shypram Pharmaceuticals Private Limited, Ragnar Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Reena Maurya was appointed as Director on 14 Nov 2021. Indresh Singh Bahadur ceased to be Director on 09 Nov 2021. Vijay Kumar Kushwaha was appointed as Director on 22 Jun 2016.
The registered office of Cherrymed Pharmaceuticals is at Railway Station Khaspur Ambedkar Nagar, Tanda, Uttar Pradesh, India – 224190.